NCT02297620View on ClinicalTrials.gov

The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

8,687

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Suglat®

oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyusyu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY